appointments, page-2

Hi Rabbitoh,

I have a instinctivly good feeling about this company and it,s technology, which reformats and enhances existing drug formulations, the management seem to be from the top end of their professional divisions and expertise, the website gives a clear and concise overview of the technology, and the CV,s of these people, I read a recent report which outlined the adversion of people to needle delivery of their medication, resulting in a great many people not keeping up their programs, seems to me, that this company, has in a short timeframe attracted a lot of eminent professionals, but in this market, as you may have noticed, a lot of things are now unsupported or ignored by traders (are there any left) ?, one other thing that I like about EIF, is that they are not in direct competition against majors, rather they are working with them, to improve on their already available drugs.